Kreston Global Life Sciences experts published in Pf Magazine

August 26, 2022

Sector: Life Sciences & Healthcare

Our global Life Sciences and Healthcare experts recently reflected on the Pharma funding climate in the global Pharma and Biotech industry, given the post-pandemic continued interest in Biotech.

The funding climate for Pharma

Having seen a slight dip in funding and activity at the end of 2021 / start of 2022, many new funds have been instituted – our Kreston firms have been involved in creating some of these – and we are optimistic about this outlook.  In addition, new virtual companies with disaggregated outsourced processes are beginning to find ways around the significant costs associated with bringing a drug or therapy to market. We are watching with interest.

About the authors

Scott Miles is the co-chair of the Kreston Global Life Sciences and Healthcare sector group. Scott is also the Life Science Lead Partner at Kreston Reeves, where he has developed a specialist team supported by David Rosevear to deliver expert services to the Life Science and Healthcare sectors.

Read the article

If you would like to read the full article, click the link here and forward to pages 28-29.